Researchers are investigating mechanisms for treating pulmonary, neurological, liver, ocular and dermatologic diseases. Scientists include Debra Laskin, Grace Guo, Lauren Aleksunes, Andrew Gow, Marion Gordon, Reynold Panettieri, Ken Reuhl, Phoebe Stapleton, Cheryl Dreyfus, Renping Zhou, and Donald Gerecke.
Studies aim to determine how exposure to environmental chemicals influence health and disease. Scientists include Jeff Laskin, Helmut Zarbl, Rob Laumbach, Howard Kipen, Keith Cooper, Lori White, Brian Buckley, Troy Roepke, Reynold Panettieri, Mehmet Uzumcu, and Stephan Schwander.
Understanding the key mechanisms responsible for cancer, disease, and carcinogenesis are critical for developing preventive approaches and novel therapies. Scientists include CS Yang, Suzie Chen, Tony Kong, Audrey Minden, Nanjoo Suh, Luca Cartegni, Rhenping Zhou, and Wei-Xing Zong.
Active research seeks to develop new drug delivery systems that improve drug efficacy and reduce adverse effects. Scientists include Pat Sinko, Bozena Michniak-Kohn, Arash Hatefi, Leonid Kagan, Guofeng You, and Tamara Minko.
Studies are ongoing to characterize patient responses to medications and design approaches that optimize therapeutic regimens. Clinicians include Mary Wagner, Luigi Brunetti, Germin Fahim, Mary Bridgeman, Megan Maroney, Laura Pizzi, Rupal Mansukhani, and Michael Toscani.
The design and synthesis of new chemical entities is critical for drug development. Scientists include Longqin Hu, David Kimball, and Edmond LaVoie.